New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Blood cancer symptoms can be vague, which is why you might want to look out for a specific sign on your skin. Some people don ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Doctor Amit Garg is known for sharing health advice on social media. He recently said there's something vital people need to ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Former Iowa Hawkeyes women's basketball player Ava Jones was forced to medically retire from the team in 2024. Now, there is ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.